Document Detail


Intermediate-term outcome and success of superior versus inferior Ahmed Glaucoma Valve implantation.
MedLine Citation:
PMID:  18854738     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: The superotemporal quadrant is usually the implantation site of choice for glaucoma drainage devices. Inferior placement of glaucoma drainage device is considered technically difficult. The purpose was to determine the success rates, complications, and visual outcome of superior versus inferior Ahmed Glaucoma Valve implantation. PATIENTS AND METHODS: A retrospective review of the records of 83 eyes (77 patients) that underwent Ahmed Glaucoma Valve surgery from 1997 to 2004. Thirty-one eyes had superior insertion (SI) versus 52 eyes with inferior insertion (II). Demographic, preoperative, and postoperative data including intraocular pressure (IOP), visual acuity, and number of medications, and complications were recorded. Success was defined as postoperative IOP between 5 and 21 mm Hg and at least a 20% reduction from baseline IOP. RESULTS: The mean postoperative IOPs at 6 months, 1, 2, 2.5, and 3 years were 13.5+/-3.2 mm Hg versus 12.8+/-3.6 mm Hg (P=0.76), 12.5+/-3.1 mm Hg versus 13.0+/-4.0 mm Hg (P=0.5), 15.7+/-6.2 mm Hg versus 12.6+/-4.7 mm Hg (P=0.06), 13.2+/-3.0 mm Hg versus 12.6+/-3.3 mm Hg (P=0.70), and 14.5+/-3.0 mm Hg versus 13.7+/-5.0 mm Hg (P=0.73) in the SI group versus the II group, respectively. The success rates were similar between the groups over the study period with 87.0% versus 86.5%, 71.5% versus 73.0%, and 71.5% versus 64.6% for SI versus II at 12, 24, and 36 months, respectively. There were more complications in the II group; however, only wound dehiscence and transient diplopia were statistically significant (P=0.04 and 0.001, respectively). The number of glaucoma medications was lower in the SI during the first 3 months but nonsignificant thereafter. CONCLUSIONS: There was no significant difference in IOP control between SI and II over 36 months. II should be considered when there are limitations to SI.
Authors:
Rony Rachmiel; Graham E Trope; Yvonne M Buys; John G Flanagan; Mary L Chipman
Related Documents :
3050678 - A clinical trial of timolol and epinephrine in the treatment of primary open-angle glau...
18794678 - Development of a prediction rule to estimate the probability of acceptable intraocular ...
10321528 - Intraoperative application versus postoperative mitomycin c eye drops in pterygium surg...
464868 - Multivariate analysis of the risk of glaucomatous visual field loss.
24391038 - Evaluation of endovascular abdominal aortic aneurysm repair in nonagenarians.
9063408 - Hemophagocytic lymphohistiocytosis in infancy and childhood.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of glaucoma     Volume:  17     ISSN:  1536-481X     ISO Abbreviation:  J. Glaucoma     Publication Date:    2008 Oct-Nov
Date Detail:
Created Date:  2008-10-15     Completed Date:  2009-01-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9300903     Medline TA:  J Glaucoma     Country:  United States    
Other Details:
Languages:  eng     Pagination:  584-90     Citation Subset:  IM    
Affiliation:
rachmiel_r@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Antihypertensive Agents / therapeutic use
Female
Glaucoma / drug therapy,  physiopathology,  surgery*
Glaucoma Drainage Implants*
Humans
Intraocular Pressure / drug effects,  physiology
Male
Middle Aged
Postoperative Complications
Prosthesis Implantation / methods*
Retrospective Studies
Treatment Outcome
Visual Acuity
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term comparison of primary trabeculectomy with 5-fluorouracil versus mitomycin C in West Africa...
Next Document:  Needle revision of filtering blebs.